WPP : Publication of Circular & Notice of GM

Publication of Circular & Notice of GM

Released : 07 Oct 2019 17:16

RNS Number : 0506P

WPP PLC

07 October 2019

For Immediate Release

7 O c t o b e r 2 0 1 9

WPP PLC ("WPP")

Publication of Circular and Notice of General Meeting

On 12 July 2019, WPP announced that it had entered into an agreement to sell 60% of Kantar, its global data, research, consulting and analytics business, to Bain Capital (the "Transaction"). The Transaction creates a strong partnership for the development and growth of Kantar.

The Transaction is conditional on, amongst other things, the approval of WPP shareholders. WPP has today published a circular in connection with the Transaction (the "C i r c u l a r") containing a notice convening a General Meeting of the Company which is to be held at the offices of Allen & Overy LLP at One Bishops Square, London E1 6AD at 11 a.m. on 24 October 2019 at which an ordinary resolution will be proposed for WPP shareholders to approve the Transaction (the "Notice of General Meeting").

The Circular and the Notice of General Meeting have been submitted to the Financial Conduct Authority's National Storage Mechanism (the "N S M") and will be available for inspection on the NSM's website at www.morningstar.co.uk/uk/nsm. These documents will also be available on the WPP website at www.wpp.com/investors.

F u r t h e r i n f o r m a t i o n :
Investors and analysts
Peregrine Riviere	[phone]
Lisa Hau	[phone]
Fran Butera (US)	[phone]
Media:
Chris Wade	[phone]
Kevin McCormack (US)	[phone]
Juliana Yeh (APAC)	[phone]
Richard Oldworth,	[phone]
Buchanan	[phone]
Communications

A b o u t W P P

WPP is a creative transformation company. We build better futures for our clients through an integrated offer of communications, experience, commerce and technology . For more information visit www.wpp.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] visit www.rns.com.

END

MSCQDLFBKBFFFBZ